Bavarian Nordic AS

BV3

Company Profile

  • Business description

    Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora and Vivotif.

  • Contact

    Philip Heymans Alle 3
    Hellerup2900
    DNK

    T: +45 33268383

    E: [email protected]

    https://www.bavarian-nordic.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    1,653

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,579.9050.100.59%
CAC 407,898.1644.690.57%
DAX 4023,835.37139.780.59%
Dow JONES (US)42,322.75271.690.65%
FTSE 1008,668.9935.240.41%
HKSE23,345.05108.11-0.46%
NASDAQ19,112.3234.49-0.18%
Nikkei 22537,753.721.79-0.00%
NZX 50 Index12,786.7994.03-0.73%
S&P 5005,916.9324.350.41%
S&P/ASX 2008,343.7046.200.56%
SSE Composite Index3,367.4613.36-0.40%

Market Movers